Serbia - Sold Production of Medicaments of Alkaloids or Derivatives Thereof Packaged for Retail Sale
Since 2014, Serbia Sold Production of Medicaments of Alkaloids or Derivatives Thereof Packaged for Retail Sale decreased by 15.1% year on year. With €29,271,782.87 in 2019, the country was ranked number 9 comparing other countries in Sold Production of Medicaments of Alkaloids or Derivatives Thereof Packaged for Retail Sale. Serbia is overtaken by Bulgaria, which was ranked number 8 at €31,046,215.11 and is followed by Spain at €26,377,351.6. Germany lead the ranking with €2,350,575,277.14 in 2019, that is -3.4% compared to 2018. United Kingdom, Poland and Hungary respectively ranked number 2, 3 and 4 in this ranking. Estonia recorded the best 5 years average growth at +11.1% per year, while Netherlands was the worst growing country at -38.7% per year.
Loading...
| Date | Euros |
|---|---|
| 2019 | 29,271,782.87 |
| 2018 | 27,170,379.00 |
| 2017 | 26,558,534.00 |
| 2016 | 32,965,360.00 |
| 2015 | 69,040,477.00 |
How does Serbia rank in Sold Production of Medicaments of Alkaloids or Derivatives Thereof Packaged for Retail Sale?
| # | 17 Countries | Euros | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Germany
|
2,350,575,277.14 | 2019 | -3.4 % | +8.0 % | View data | |
| 2 |
#2
United Kingdom
|
195,933,082.68 | 2019 | +2.5 % | -5.9 % | View data | |
| 8 |
#8
Bulgaria
|
31,046,215.11 | 2019 | -1.8 % | +8.5 % | View data | |
| 9 |
#9
Serbia
|
29,271,782.87 | 2019 | +7.7 % | -15.1 % | View data | |
| 10 |
#10
Spain
|
26,377,351.60 | 2019 | -12.7 % | +9.5 % | View data | |